Net Cash Provided by (Used in) Operating Activities |
254M |
USD |
+235% |
Q1 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Financing Activities |
-21.6M |
USD |
-201% |
Q1 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Investing Activities |
-359M |
USD |
-228% |
Q1 2024 |
Q1 2024 |
Common Stock, Shares Authorized |
200K |
shares |
0% |
Q3 2024 |
Q3 2024 |
Common Stock, Shares, Issued |
145K |
shares |
0% |
Q3 2024 |
Q3 2024 |
Common Stock, Par or Stated Value Per Share |
100 |
USD/shares |
0% |
Q3 2024 |
Q3 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
-127M |
USD |
-923% |
Q1 2024 |
Q1 2024 |
Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
103M |
USD |
-35.8% |
Q3 2024 |
Q3 2024 |
Deferred Income Tax Expense (Benefit) |
-3.7M |
USD |
-429% |
Q1 2024 |
Q1 2024 |
Preferred Stock, Shares Issued |
310K |
shares |
0% |
Q3 2024 |
Q3 2024 |
Preferred Stock, Shares Authorized |
450K |
shares |
0% |
Q3 2024 |
Q3 2024 |
Additional Paid in Capital |
178M |
USD |
+4.64% |
Q3 2024 |
Q3 2024 |
Preferred Stock, Shares Outstanding |
310K |
shares |
0% |
Q3 2024 |
Q3 2024 |
Preferred Stock, Par or Stated Value Per Share |
100 |
USD/shares |
0% |
Q3 2024 |
Q3 2024 |